Clinical Trial: Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159243) titled 'Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain' on Aug. 12.

Brief Summary: This is a multi-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and PK parameter of HL-1186 tablet for diabetic peripheral neuropathic pain.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Diabetic Peripheral Neuropathic Pain

Intervention: DRUG: HL-1186

HL-1186 tablet for oral administration.

DRUG: HL-1186

HL-1186 tablet for oral administration.

DRUG: HL-1186 placebo

HL-1186 placebo tablet for oral administration.

Recruitment S...